Navigation Links
AMPAC Fine Chemicals Continues to Invest in Quality Systems
Date:2/14/2012

RANCHO CORDOVA, Calif., Feb. 14, 2012 /PRNewswire/ -- AMPAC Fine Chemicals LLC (AFC), a wholly owned subsidiary of American Pacific Corporation (Nasdaq: APFC), reports that it has joined Rx-360 as an active member.  Rx-360 is a pharmaceutical and biotech industry consortium that was founded by industry leaders to enhance the security of the pharmaceutical supply chain and to assure the quality and authenticity of the products moving through the supply chain.  AFC is contributing to the Rx-360's joint audit pilot program as the first U.S.-based active pharmaceutical ingredient (API) manufacturer to be audited.

AFC's ongoing focus and commitment to quality has resulted in a successful U.S. Food and Drug Administration (FDA) pre-approval inspection (PAI) for seven oncology and anti-viral products, subsequently resulting in FDA approval for several of these products.  This is the latest of several successful inspections at the AFC Rancho Cordova, California, facility over the past year, including a combined FDA PAI and general inspection, and inspections by the Korean FDA (KFDA) and the European Medicines Agency (EMA).

"We continue to invest in our quality systems and this is demonstrated by our successful inspections by the FDA, KFDA and EMA.  In 2011, we were also re-accredited by the Japanese PMDA," stated Jeff Robinson, Vice President of Quality and Regulatory Affairs.  "With our recent inspections and active participation in Rx-360's audit program, we continue to validate our commitment to quality and transparency."

"Successful audits by various regulatory agencies coupled with AFC joining Rx-360 substantiates our commitment to Quality and to AFC's Continuous Improvement Initiative," stated Aslam Malik, President AMPAC Fine Chemicals.

ABOUT Rx-360
Rx-360 was formed in 2009 to support an industry-wide commitment to ensuring patient safety by enhancing quality and authenticity throughout the supply chain.  The mission of the new organization is timely in light of growing attacks and threats to an increasingly complex and global supply chain.  Millions of people around the world are treated every day with the vital medicines that pharmaceutical and biotechnology companies provide.  Management of the pharmaceutical supply chain has become one of the top public health concerns with respect to consumer safety.  The globalization of distribution for both drug components and finished products has introduced many complications that Rx-360 is positioned to help resolve.  To learn more about Rx-360 go to the Rx-360 website at www.Rx-360.org.

ABOUT AMPAC FINE CHEMICALS LLC
AFC is a U.S.-based company with demonstrated capabilities in process development, scale-up, and cGMP-compliant commercial production of active pharmaceutical ingredients (API's) and registered intermediates for pharmaceutical and biotechnology customers.  Its specially engineered facilities and experienced staff allow AFC to safely produce highly energetic compounds at commercial scale.  In addition, AFC's other technology platforms include production of highly potent compounds, continuous processes and industrial-scale chromatographic separation using simulated moving bed chromatography (SMB).  AFC's operations are located in Rancho Cordova, CA and in La Porte, Texas.  Additional information about us can be obtained by visiting our web site at www.ampacfinechemicals.com.

ABOUT AMERICAN PACIFIC CORPORATION
American Pacific Corporation (AMPAC) is a leading custom manufacturer of fine chemicals, specialty chemicals and propulsion products within its focused markets.  We supply active pharmaceutical ingredients and advanced intermediates to the pharmaceutical industry.  For the aerospace and defense industry we provide specialty chemicals used in solid rocket motors for space launch and military missiles. AMPAC also designs and manufactures liquid propulsion systems, valves and structures for space and missile defense applications.  We produce clean agent chemicals for the fire protection industry, as well as electro-chemical equipment for the water treatment industry.  Our products are designed to meet customer specifications and often must meet certain governmental and regulatory approvals.  Additional information about us can be obtained by visiting our web site at www.apfc.com.Technical Contact:

William DuBay, Ph.D., Vice President, 

Technology and Business Development 

AMPAC Fine Chemicals 

+1 (800) 311-9668 

+1 (916) 357-6880 

 Investor Contact:

Deanna Riccardi 

American Pacific Corporation 

+1 (702) 735-2200


'/>"/>
SOURCE American Pacific Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. AMPAC Fine Chemicals Completes Contract Manufacturing Agreement for Smallpox Countermeasure API
2. AMPAC Fine Chemicals Validates Continuous Extraction Process for API Manufacture
3. AMPAC Fine Chemicals Announces the Inauguration of the New cGMP Continuous Processing Development Facility
4. AMPAC Fine Chemicals Receives the California Pollution Prevention Challenge Award Two Consecutive Years
5. Bio architecture lab technology converts seaweed to renewable fuels and chemicals
6. Reportlinker Adds Global Immunochemicals Industry
7. Mitsubishi Chemical Corporation Signs Memorandum of Understanding for Strategic Partnership With Genomatica for Sustainable Chemicals in Asia
8. Agrivida Announces Collaboration With Syngenta Ventures to Deliver Low-Cost Sugars for Cellulosic Biofuels and Biochemicals
9. Chemicals study pinpoints threat to workers lungs
10. AloeSafe™ Hand Sanitizer is Free From Toxic Chemicals
11. 21st Century Biochemicals Marks Its Third Consecutive Year on the Inc. 5000
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... ... a new agreement with Singapore-based Global Stem Cells Network (GSCN) and its affiliate ... and Singapore in the latest adipose and bone marrow therapies. , Through ...
(Date:2/9/2016)... ... , ... Date and time: March 1, 2016, 5:30 p.m. ... Center of Bucks County, 3805 Old Easton Road, Doylestown, PA 18902. , The ... open house for participants to learn about a new Master of Biomedical Science ...
(Date:2/9/2016)... CA (PRWEB) , ... February 09, 2016 , ... ... strategic changes over the years and Open Access publishing is one of the ... With its 700+ open access journals and 3000+ International Conferences ...
(Date:2/9/2016)... Three-Year Initiative Supports Next Generation of ... in Life-Changing Camp Experiences ... affect the lives of children born with rare diseases, as well ... ) is announcing a new initiative designed to positively affect the ... future of rare disease care. --> To mark the ...
Breaking Biology Technology:
(Date:2/9/2016)... 2016 Vigilant Solutions announces today that an agency ... develop a lead in a difficult homicide case. The agency ... locate the suspect vehicle. Due to the ongoing investigation, the ... omitted at the agency,s request. --> ... victim was found deceased at an intersection here in the ...
(Date:2/3/2016)... , February 3, 2016 ... market research report "Automated Fingerprint Identification System Market by ... Search), Application (Banking & Finance, Government, Healthcare, and Transportation) ... MarketsandMarkets, the market is expected to be worth USD ... 21.0% between 2015 and 2020. The transformation and technology ...
(Date:2/2/2016)... Feb. 2, 2016 Checkpoint Inhibitors for ... Market Are you interested in the future ... for checkpoint inhibitors. Visiongain,s report gives those predictions ... and national level. Avoid falling behind in ... opportunities and revenues those emerging cancer therapies can ...
Breaking Biology News(10 mins):